News on Hepatitis continually updated from thousands of sources around the net.
52 min ago | Forbes.com
Last month, Eugene Groysman made the case that Gilead Sciences can double its stock price because of high demand for its new Hepatitis-C drug, Sovaldi, even though it costs $84,000 per treatment.
Trending on the Topix Network
CHINO >> Daniel Luevanos, 55, will be competing in the national Transplant Games in Houston starting today representing Southern California, but his journey to this point has been anything but smooth.
Of the nearly 16,000 people on waiting lists for a liver transplant, approximately 10 percent die before they are chosen for surgery.
Maintaining the momentum of scientific discoveries and breakthroughs is critical to preventing further HIV infections, improving care for the 35 million people living with HIV and because other critical global health priorities compete for funding in our fiscally-constrained world.
Imphal, July 10: The Hepatitis-C co-infection among drug users and people living with HIV in Manipur has become a serious health problem with the state government groping in the dark to tackle the situation, experts said.
In a split decision, the Nevada Supreme Court ruled today that a Las Vegas man cannot sue a health maintenance organization for sending him to the clinic where there was an outbreak of hepatitis in 2008.
More than 600 Vermonters have chronic hepatitis C. The disease was the second most commonly tracked by public health officials last year, according to data from the Vermont Department of Health.
France said Thursday it has joined forces with 13 other European countries to negotiate a lower price for a promising new hepatitis C drug that has drawn controversy for its astronomical cost.
Su Wang, medical director of The Center for Asian Health at Saint Barnabas, in her West Orange office.
Bristol-Myers Squibb's all-oral dual regimen of daclatasvir plus asunaprevir has been approved for the treatment of chronic hepatitis C in Japan, where most people are infected with HCV genotype 1b, the company announced this week.
Since introduction of its new breakthrough drug Sovaldi, which comes close to "curing" Hepatitis C, Gilead has been under intense public scrutiny because the three-month course of therapy "is too expensive."
A North Carolina-based, company-owned Papa John's location has been identified as the original source of a hepatitis A outbreak that happened in late March/early April.
Chronic disease develops in 60-85% of patients, with cirrhosis representing a major hallmark of HCV infection.
The following quote was obtained by the news editors from the background information supplied by the inventors: "Previously, non-alcoholic fatty liver disease was believed to be a benign disease that does not progress.
According to a new market report published by Transparency Market Research "Safety Syringes Market Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," the global safety syringes market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value ... (more)
Last month, the FDA took a much-anticipated step by issuing guidelines for drug makers that want to use social media, including examples of how to run paid search links on Google.
Updated: Fri Jul 11, 2014 07:12 am
Copyright © 2014 Topix LLC